Login / Signup

Comparative Efficacy and Safety of Statin Monotherapy and Statin plus Ezetimibe Combination in a Real-World Setting.

Marat V EzhovIgor V SergienkoSergey M KryzhanovskiyKirill S MankoElena V Timoshina
Published in: Diseases (Basel, Switzerland) (2023)
In real-world clinical practice, statin/ezetimibe combination therapy demonstrated a more frequent achievement of target LDL-C levels compared with statin monotherapy. The addition of ezetimibe to statin therapy increased the probability of achieving LDL-C level goals by 29%.
Keyphrases
  • combination therapy
  • low density lipoprotein
  • cardiovascular disease
  • coronary artery disease
  • clinical practice
  • open label
  • clinical trial
  • global health
  • replacement therapy